Cargando…
Magnetic Resonance Imaging in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a rapidly progressing neurodegenerative disorder which is incurable to date. As there are many ongoing studies with therapeutic candidates, it is of major interest to develop biomarkers not only to facilitate early diagnosis but also as a monitoring tool to pre...
Autores principales: | Kollewe, Katja, Körner, Sonja, Dengler, Reinhard, Petri, Susanne, Mohammadi, Bahram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400399/ https://www.ncbi.nlm.nih.gov/pubmed/22848820 http://dx.doi.org/10.1155/2012/608501 |
Ejemplares similares
-
Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited
por: Kollewe, Katja, et al.
Publicado: (2015) -
Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort
por: Körner, Sonja, et al.
Publicado: (2015) -
Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options
por: Körner, Sonja, et al.
Publicado: (2013) -
Interhemispheric connectivity in amyotrophic lateral sclerosis: A near-infrared spectroscopy and diffusion tensor imaging study
por: Kopitzki, Klaus, et al.
Publicado: (2016) -
Structural and diffusion imaging versus clinical assessment to monitor amyotrophic lateral sclerosis
por: Cardenas-Blanco, Arturo, et al.
Publicado: (2016)